GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...

It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Viking Therapeutics' leading candidate, VK2735, is a potential GLP-1 weight loss medicine. It reported ...

Did you know that back in the 1980s and '90s, when South Korea was on the road toward becoming—but had yet to become—the ...

The ceremony saw the individuals awarded diplomas in various health fields, including Clinical Medicine, Pharmaceutical Science, Health Records and Information Technology as well as Community ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

ASD Specialty Healthcare LLC, trading as Besse Medical, has reached a $1.67 million settlement to resolve allegations of ...

In a move designed to advance its pipeline and its “innovative medicines business,” Chinese biotech Hutchmed will ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England, which develops inhaled medicines and ...

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...